both conditions at the same time effectively was difficult and revealed that 43% of their asthma patients are treated with only quick relief medications and. Even though 85% of physicians agreed that both the asthma and AR symptoms should be treated, a fifth of surveyed physicians managing the most troublesome condition first and only 68% believed that intra-nasal corticosteroids (INS) and inhaled corticosteroids (ICS) should be given concurrently to patients. 55% of the surveyed physicians thought that patients prefer oral medications over inhaled medications and nasal sprays and approximately 36% of believed that the initiation of INS and ICS should be delayed in children for both asthma and AR.
rently to patients. 55% of the surveyed physicians thought that patients prefer oral medications over inhaled medications and nasal sprays and approximately 36% of believed that the initiation of INS and ICS should be delayed in children for both asthma and AR.
Conclusion:
The results from the ASPAIR survey in India highlight the need for increased communication and awareness for appropriate management of co-existent asthma-AR, particularly regarding use of INS and ICS, to improve patient outcomes.
Funding: GSK (206753 Background and Aims: Metabolomics was a valuable tool for the discovery of biomarkers and for the elucidation of complex mechanisms in asthma. The aim of this study was to investigate the changes of arachidonic acid metabolites in dust mite sensitized children in allergen-specific immunotherapy (AIT) by metabolomics methods.
Methods:
In this study, we enrolled 15 asthma children, 15 Dust mite sensitized asthma children and 10 Dust mite sensitized asthma children, finished three years allergen immunotherapy. All of the serum were processed using ethyl acetate and derivatized using (2-aminoethyl) trimethylammonium chloride hydrochloride (cholamine) reagent, then analyzed and profiled by ultra-high performance liquid chromatography-quadruple-time of flight/MS (UHPLC-Q-TOF/MS) and reported as relevant concentrations.
Results:
The dust mite sensitized asthmatic children group 15 (S), -HETE, 12 (S) -HETE and 5 (S)-HETE showed much higher signal intensity than the healthy children group, suggesting that the three metabolites have the potential of new biomarkers. The dust mite sensitized asthmatic children group 15 (S), -HETE, 12 (S) -HETE and 5 (S)-HETE showed much higher signal intensity than the healthy children group, suggesting that the three metabolites have the potential of new biomarkers. Moreover, in the LOX pathway, the metabolites of asthmatic children were higher than those of the Healthy group. These important metabolite levels increased first and then decreased, 0Y was higher than 3Y, and 1Y levels were highest
Conclusion: This suggested that HETEs were the potential biomarkers of asthma and Gpx4 might play important role in the regulation of the content of HETEs in asthma human serum, and may be used as biological indicators of therapeutic monitoring during AIT treatment. Corresponding metabolic enzymes (COX and LOX), might be not only involved in asthma pathophysiology but also represent the therapeutic target for AIT. The aim of this study is to evaluate the real need of oxygen therapy during air-travel in patients with lung disease and resting oxygen saturation (SpO 2 ) above 95%.
Methods: This is a retrospective review of all HASTs that were performed in our hospital between 1st January 2015 and 31st July 2017. We excluded pediatric patients and patients with non-pulmonary diseases (cardiac pathologies, neurological pathologies and patients with advanced chronic illnesses). We included patients with pulmonary diagnosis such as asthma, chronic obstructive pulmonary disease, bronchiectasis, lung fibrosis and lung cancer.
Results: A total of 276 HAST results were collected. 209 were for adults, out of which 77 had an underlying pulmonary disease and not on Long term oxygen therapy at home. The median age was 66 years, and 54% of the patients were female. Out of the 77 patients 56 had SpO2 equal of above 95% and 21 had a SpO 2 below 95%. Among those with SpO 2 equal or above 95%, 45 patients (80%) needed supplemental oxygen therapy with average flow rate of 1.5 L/min. As for the other group with SpO 2 below 95%, all of them needed oxygen therapy during the HAST with an average flow rate of 2.5 L/min.
Conclusion:
This study showed that 80% of the patients with pulmonary diseases and normal baseline SpO2 who underwent HAST required supplemental oxygen therapy during air travel. Further studies are needed to elaborate more on performing routine HAST prior to air travel in patients with serious and/or advanced pulmonary diseases who have a normal oxygen saturation on room air. Background and Aims: The symptoms of iron pill aspiration are non-specific and delay in diagnosis and removal leads to marked mucosal inflammation, necrosis, and bronchial stenosis. Moreover, it is often difficult to make the diagnosis by identifying the aspirated tablets on computed tomography(CT) because the iron pill disintegrates easily after aspiration. We describe 2 cases of serious bronchial injury due to the iron pill aspiration, which showed characteristic high attenuation areas along the bronchial wall.
Methods: Case 1: A 91-year-old woman who was admitted to our hospital for dyspnea presented with bilateral wheeze despite normal chest radiograph findings. A chest CT scan showed stenosis of the left main bronchus and a high attenuation lesion around the bronchial wall ( Figure 1A ). Bronchoscopy revealed nearly total obstruction of the left main bronchus by a pill-like object, which stained positive for iron ( Figure 1B) . Furthermore, the endobronchial mucosa was haemorrhagic and yellowish-brown in colour ( Figure 1C) . A detailed history revealed her habit of taking iron tablets. One month after, bronchoscopy showed
